Nations Financial Group Inc. IA ADV Sells 426 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Nations Financial Group Inc. IA ADV reduced its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1.4% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 29,937 shares of the exchange traded fund’s stock after selling 426 shares during the quarter. Nations Financial Group Inc. IA ADV’s holdings in SPDR S&P Biotech ETF were worth $2,696,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Golden State Wealth Management LLC bought a new position in shares of SPDR S&P Biotech ETF during the 4th quarter valued at approximately $29,000. Avior Wealth Management LLC boosted its position in shares of SPDR S&P Biotech ETF by 393.6% during the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after acquiring an additional 307 shares during the last quarter. Tidemark LLC boosted its position in shares of SPDR S&P Biotech ETF by 101.5% during the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after acquiring an additional 199 shares during the last quarter. Quintet Private Bank Europe S.A. bought a new stake in SPDR S&P Biotech ETF in the third quarter worth $40,000. Finally, Howe & Rusling Inc. bought a new stake in SPDR S&P Biotech ETF in the third quarter worth $49,000.

SPDR S&P Biotech ETF Stock Up 0.7 %

Shares of XBI opened at $91.41 on Friday. The company has a market cap of $6.97 billion, a PE ratio of 11.47 and a beta of 1.11. The business has a fifty day moving average of $91.77 and a 200 day moving average of $96.13. SPDR S&P Biotech ETF has a 52-week low of $81.14 and a 52-week high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.